139 research outputs found

    Infección oral y cervicofacial por agranulocitosis secundario debido al tratamiento con medicación antitiroidea: Reporte de Caso

    Get PDF
    Agranulocytosis refers to a low white blood cell count, specifically neutrophils, which can be caused by certain medications such as antithyroid drugs (ATD). This condition can result in oral manifestations, including diffuse gingival ulceration or necrosis. We present the case of a 26-year-old female patient with a history of hyperthyroidism who came to the emergency department of Alberto Sabogal Sologuren National Hospital with swelling on the left side of her face, accompanied by dysphagia, multiple ulcerated lesions in the oral mucosa involving bone tissue, as well as fever and general malaise. After conducting additional tests, the patient was diagnosed with oral and cervicofacial infection secondary to agranulocytosis caused by methimazole treatment. While the global literature reports cases of agranulocytosis as an adverse effect of antithyroid medication, with documented oral manifestations, only a few cases demonstrate cervical involvement. Therefore, we present this uncommon case from diagnosis to treatment.La agranulocitosis es el recuento bajo de glóbulos blancos (neutrófilos), que puede ser inducida por tratamientos con algunos medicamentos como los antitiroideos, que ocasionan manifestaciones orales como úlceras o necrosis gingival difusa. Se presenta el caso de una paciente mujer de 26 años, con antecedente de hipertiroidismo, quien acude a emergencia del Hospital Nacional Alberto Sabogal Sologuren por presentar tumefacción en la hemicara izquierda, asociada a disfagia, múltiples lesiones ulceradas en mucosa oral, con compromiso de tejido óseo, fiebre y malestar general. Luego de los exámenes auxiliares, se categoriza como una infección oral y cervicofacial por agranulocitosis debido al tratamiento con el metimazol. La literatura mundial reporta casos de agranulocitosis como efecto adverso del consumo de drogas antitiroideas, con reporte de manifestaciones orales; sin embargo, pocos casos evidencian compromiso cervical. Por lo cual se presenta este caso poco usual desde su diagnóstico hasta el tratamiento

    Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Get PDF
    Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

    Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

    Get PDF
    Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

    Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M<sup>PRO</sup>

    No full text
    El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.SARS-CoV-2 main protease is a common target for inhibition assays due to its high conservation among coronaviruses. Since flavonoids show antiviral activity, several in silico works have proposed them as potential SARS-CoV-2 main protease inhibitors. Nonetheless, there is reason to doubt certain results given the lack of consideration for flavonoid promiscuity or main protease plasticity, usage of short library sizes, absence of control molecules and/or the limitation of the methodology to a single target site. Here, we report a virtual screening study where dorsilurin E, euchrenone a11, sanggenol O and CHEMBL2171598 are proposed to inhibit main protease through different pathways. Remarkably, novel structural mechanisms were observed after sanggenol O and CHEMBL2171598 bound to experimentally proven allosteric sites. The former drastically affected the active site, while the latter triggered a hinge movement which has been previously reported for an inactive SARS-CoV main protease mutant. The use of a curated database of 4.8 k flavonoids, combining two well-known docking software (AutoDock Vina and AutoDock4.2), molecular dynamics and MMPBSA, guaranteed an adequate analysis and robust interpretation. These criteria can be considered for future screening campaigns against SARS-CoV-2 main protease.Consejo Nacional de Ciencia, Tecnología e Innovación TecnológicaRevisión por pare

    Search for CPCP violation in D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S} decays in proton-proton collisions at s\sqrt{s} = 13 TeV

    No full text
    International audienceA search is reported for charge-parity D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S}CPCP violation in D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S} decays, using data collected in proton-proton collisions at s\sqrt{s} = 13 TeV recorded by the CMS experiment in 2018. The analysis uses a dedicated data set that corresponds to an integrated luminosity of 41.6 fb1^{-1}, which consists of about 10 billion events containing a pair of ẖadrons, nearly all of which decay to charm hadrons. The flavor of the neutral D meson is determined by the pion charge in the reconstructed decays D+^{*+}\to D0π+^0\pi^+ and D^{*-}\to D0π^0\pi^-. The D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S}CPCP asymmetry in D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S} is measured to be ACPA_{CP}( KS0^0_\mathrm{S}KS0^0_\mathrm{S}) = (6.2 ±\pm 3.0 ±\pm 0.2 ±\pm 0.8)%, where the three uncertainties represent the statistical uncertainty, the systematic uncertainty, and the uncertainty in the measurement of the D0^0 \to KS0^0_\mathrm{S}KS0^0_\mathrm{S} CPCP asymmetry in the D0^0 \to KS0π+π^0_\mathrm{S}\pi^+\pi^- decay. This is the first D0^0 \to KS0^0_\mathrm{S}KS0^0_\mathrm{S} CPCP asymmetry measurement by CMS in the charm sector as well as the first to utilize a fully hadronic final state

    Search for heavy neutral leptons in final states with electrons, muons, and hadronically decaying tau leptons in proton-proton collisions at s\sqrt{s} =13 TeV

    No full text
    International audienceA search for heavy neutral leptons (HNLs) of Majorana or Dirac type using proton-proton collision data at s\sqrt{s} =13 TeV is presented. The data were collected by the CMS experiment at the CERN LHC and correspond to an integrated luminosity of 138 fb1^{-1}. Events with three charged leptons (electrons, muons, and hadronically decaying tau leptons) are selected, corresponding to HNL production in association with a charged lepton and decay of the HNL to two charged leptons and a standard model (SM) neutrino. The search is performed for HNL masses between 10 GeV and 1.5 TeV. No evidence for an HNL signal is observed in data. Upper limits at 95% confidence level are found for the squared coupling strength of the HNL to SM neutrinos, considering exclusive coupling of the HNL to a single SM neutrino generation, for both Majorana and Dirac HNLs. The limits exceed previously achieved experimental constraints for a wide range of HNL masses, and the limits on tau neutrino coupling scenarios with HNL masses above the W boson mass are presented for the first time

    Search for nuclear modifications of B+^+ meson production in pPb collisions at sNN\sqrt{s_\mathrm{NN}} = 8.16 TeV

    No full text
    International audienceNuclear medium effects on B+^+ meson production are studied using the binary-collision scaled cross section ratio between events of different multiplicities from proton-lead collisions. Data, collected by the CMS experiment in 2016 at a nucleon-nucleon center-of-mass energy of sNN\sqrt{s_\mathrm{NN}} = 8.16 TeV, corresponding to an integrated luminosity of 175 nb1^{-1}, were used. The scaling factors in the ratio are determined using a novel approach based on the Z \toμ+μ\mu^+\mu^- cross sections measured in the same events. The scaled ratio for B+^+ is consistent with unity for all event multiplicities, putting stringent constraints on nuclear modification for heavy flavor

    Search for long-lived heavy neutral leptons in proton-proton collision events with a lepton-jet pair associated with a secondary vertex at s\sqrt{s} = 13 TeV

    No full text
    International audienceA search for long-lived heavy neutral leptons (HNLs) using proton-proton collision data corresponding to an integrated luminosity of 138 fb1^{-1} collected at s\sqrt{s} = 13 TeV with the CMS detector at the CERN LHC is presented. Events are selected with a charged lepton originating from the primary vertex associated with the proton-proton interaction, as well as a second charged lepton and a hadronic jet associated with a secondary vertex that corresponds to the semileptonic decay of a long-lived HNL. No excess of events above the standard model expectation is observed. Exclusion limits at 95% confidence level are evaluated for HNLs that mix with electron and/or muon neutrinos. Limits are presented in the mass range of 1-16.5 GeV, with excluded square mixing parameter values reaching as low as 2 ×\times 107^{-7}. For masses above 11 GeV, the presented limits exceed all previous results in the semileptonic decay channel, and for some of the considered scenarios are the strongest to date

    Search for CPCP violation in D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S} decays in proton-proton collisions at s\sqrt{s} = 13 TeV

    No full text
    International audienceA search is reported for charge-parity D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S}CPCP violation in D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S} decays, using data collected in proton-proton collisions at s\sqrt{s} = 13 TeV recorded by the CMS experiment in 2018. The analysis uses a dedicated data set that corresponds to an integrated luminosity of 41.6 fb1^{-1}, which consists of about 10 billion events containing a pair of ẖadrons, nearly all of which decay to charm hadrons. The flavor of the neutral D meson is determined by the pion charge in the reconstructed decays D+^{*+}\to D0π+^0\pi^+ and D^{*-}\to D0π^0\pi^-. The D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S}CPCP asymmetry in D0^0\to KS0^0_\mathrm{S}KS0^0_\mathrm{S} is measured to be ACPA_{CP}( KS0^0_\mathrm{S}KS0^0_\mathrm{S}) = (6.2 ±\pm 3.0 ±\pm 0.2 ±\pm 0.8)%, where the three uncertainties represent the statistical uncertainty, the systematic uncertainty, and the uncertainty in the measurement of the D0^0 \to KS0^0_\mathrm{S}KS0^0_\mathrm{S} CPCP asymmetry in the D0^0 \to KS0π+π^0_\mathrm{S}\pi^+\pi^- decay. This is the first D0^0 \to KS0^0_\mathrm{S}KS0^0_\mathrm{S} CPCP asymmetry measurement by CMS in the charm sector as well as the first to utilize a fully hadronic final state

    Bottom quark energy loss and hadronization with B+^+ and Bs0^0_\mathrm{s} nuclear modification factors using pp and \PbPb collisions at sNN\sqrt{s_\mathrm{NN}} = 5.02 TeV

    No full text
    International audienceThe production cross sections of Bs0^0_\mathrm{s} and B+^+ mesons are reported in proton-proton (pp) collisions recorded by the CMS experiment at the CERN LHC with a center-of-mass energy of 5.02 TeV. The data sample corresponds to an integrated luminosity of 302 pb1^{-1}. The cross sections are based on measurements of the Bs0^0_\mathrm{s}\to J/ψ(μ+μ)ϕ\psi(\mu^+\mu^-)\phi(1020)(K+^+K^-) and B+^+\to J/ψ(μ+μ)\psi(\mu^+\mu^-)K+^+ decay channels. Results are presented in the transverse momentum (pTp_\mathrm{T}) range 7-50 GeV/cc and the rapidity interval y\lvert y \rvert<\lt 2.4 for the B mesons. The measured pTp_\mathrm{T}-differential cross sections of B+^+ and Bs0^0_\mathrm{s} in pp collisions are well described by fixed-order plus next-to-leading logarithm perturbative quantum chromodynamics calculations. Using previous PbPb collision measurements at the same nucleon-nucleon center-of-mass energy, the nuclear modification factors, RAAR_\mathrm{AA}, of the B mesons are determined. For pTp_\mathrm{T}<\lt 10 GeV/cc, both mesons are found to be suppressed in PbPb collisions (with RAAR_\mathrm{AA} values significantly below unity), with less suppression observed for the Bs0^0_\mathrm{s} mesons. In this pTp_\mathrm{T} range, the RAAR_\mathrm{AA} values for the B+^+ mesons are consistent with those for inclusive charged hadrons and D0^0 mesons. Below 10 GeV/cc, both B+^+ and Bs0^0_\mathrm{s}s are found to be less suppressed than either inclusive charged hadrons or D0^0 mesons, with the Bs0^0_\mathrm{s}RAAR_\mathrm{AA} value consistent with unity. The RAAR_\mathrm{AA} values found for the B+^+ and Bs0^0_\mathrm{s} are compared to theoretical calculations, providing constraints on the mechanism of bottom quark energy loss and hadronization in the quark-gluon plasma, the hot and dense matter created in ultrarelativistic heavy ion collisions
    corecore